Metformin induces tumor immunogenic cell death in ovarian cancer by activating AMPK pathway
Inducing immunogenic cell death (ICD) process may be an important antitumor strategy in ovarian cancer (OC). Metformin (Met) has been shown to have antitumor effects in OC, but whether it mediates the ICD to inhibit OC process is unclear. Human OC cell lines (SKOV3 and A2780) were treated with Met....
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2024-09-01
|
| coleção: | Translational Oncology |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1936523324001797 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|